Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
Inactive Indication- |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
痛风凝胶Ⅰ期临床单次给药/多次给药人体耐受性试验验
[Translation] Phase I clinical trial of single-dose/multiple-dose human tolerance of gout gel
研究人体对痛风凝胶的耐受性与安全性,找出最大耐受剂量,并根据试验结果为Ⅱ期临床试验方案的制定提供试验依据。
[Translation] Study the human body's tolerance and safety to gout gel, find out the maximum tolerated dose, and provide a test basis for the formulation of Phase II clinical trial plan based on the test results.
100 Clinical Results associated with Shenzhen Wanxing Chuangyuan Technology Co., Ltd.
0 Patents (Medical) associated with Shenzhen Wanxing Chuangyuan Technology Co., Ltd.
100 Deals associated with Shenzhen Wanxing Chuangyuan Technology Co., Ltd.
100 Translational Medicine associated with Shenzhen Wanxing Chuangyuan Technology Co., Ltd.